therapeuticsmd inc nysemkttxmd quotes  news  google financecookies help us deliver our services by using our services you agree to our use of cookieslearn moregot itmy accountsearchmapsyoutubeplaynewsgmaildrivecalendargoogletranslatephotosmoreshoppingwalletfinancedocsbooksbloggercontactshangoutskeepeven more from googlesign inhidden fieldssearch financeadobe flash player is required for interactive charts allowfinancetherapeuticsmd incnysemkttxmdadd to portfoliocompanysummarynewsrelated companieshistorical pricesfinancialsmarketsnewsportfoliosstock screenergoogle domestic trendsrecent quotes  daysyou have no recent quoteschg   therapeuticsmd inc  public nysemkttxmd   watch this stock      after hours    jul  pm edt   nysemkt realtime data  disclaimer currency in usd range     week    open  vol  avg mm mkt cap b pe      divyield      eps  shares m beta  inst own  news relevance date all news for therapeuticsmd inc » subscribe advertisement events add txmd to my calendars aug   q  therapeuticsmd inc earnings call  pm edt  aug   q  therapeuticsmd inc earnings release jun   therapeuticsmd inc at goldman sachs global healthcare conference jun   therapeuticsmd inc at jefferies healthcare conference may   therapeuticsmd inc at bank of america merrill lynch healthcare conference may   therapeuticsmd to host txhr regulatory update conference call may   q  therapeuticsmd inc earnings release more events from dailyfinance »     key stats and ratios q mar   net profit margin   operating margin   ebitd margin   return on average assets   return on average equity   employees   cdp score   screen stocks with similar metrics » address  broken sound pkwy nwboca raton fl united states  map phone website links httpswwwtherapeuticsmdcom external links analyst estimates  marketwatch sec filings  edgar online major holders  msn money research reports  reuters settings  technicals  link to this view volume delayed by  minsprices are not from all markets sources include six advertisement related companies show most recent quarter most recent annual add or remove columns save changes cancel sector healthcare  industry specialty  advanced pharmaceuticals more from factset » description therapeuticsmd inc is a womens healthcare company engaged in creating and commercializing products for women the company is focused on pursuing regulatory approvals and precommercialization activities necessary for commercialization of its hormone therapy pharmaceutical products its drug candidates used in clinical trials are designed to alleviate symptoms of and reduce health risks resulting from menopauserelated hormone deficiencies including hot flashes osteoporosis and vaginal discomfort with its symboda technology it is developing hormone therapy pharmaceutical products to enable delivery of bioidentical hormones through dosage forms and administration routes its product line includes vitatrue vitapearl vitamedmd plus vitamedmd one prenatal multivitamin vitamedmd plus rx prenatal multivitamin vitamedmd one rx prenatal multivitamin vitamedmd iron  vitamedmd vitamin d  iu bocagreenmd prena pearl and bocagreenmd prena chew more from reuters » officers and directors tommy g thompson jd independent chairman of the board age  bio  compensation   reuters john c k milligan iv president secretary director age  bio  compensation   reuters robert g finizio chief executive officer director age  bio  compensation   reuters daniel a cartwright chief financial officer treasurer age  bio  compensation   reuters mitchell l krassan executive vice president chief strategy officer age  bio  compensation   reuters michael donegan vice president  finance age  bio  compensation   reuters brian bernick md chief clinical officer director age  bio  compensation   reuters jules a musing director age  bio  compensation   reuters j martin carroll independent director age  bio  compensation   reuters cooper c collins independent director age  bio  compensation   reuters full list on reuters » google finance beta available in hong kong  canada  us  china  ukinformation is provided as is and solely for informational purposes not for trading purposes or advice and may be delayedto see all exchange delays please see disclaimer google  google home  blog  help  report a problem  privacy policy  terms of service therapeuticsmd inc txmdk company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile therapeuticsmd inc txmdk related topics stocksstock screenerhealthcarepharmaceuticals overview news key developments people charts financials analysts research pulse txmdk on american stock exchange usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description therapeuticsmd inc incorporated on july   is a womens healthcare company which is engaged in creating and commercializing products for women the company is focused on pursuing the regulatory approvals and precommercialization activities necessary for commercialization of its hormone therapy pharmaceutical products the companys drug candidates used in its clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopauserelated hormone deficiencies including hot flashes osteoporosis and vaginal discomfort with its symboda technology it is developing hormone therapy pharmaceutical products to enable delivery of bioidentical hormones through a variety of dosage forms and administration routes in addition the company manufactures and distributes branded and generic prescription prenatal vitamins as well as overthecounter otc iron supplementsthe company manufactures and distributes its prescription and otc product lines consisting of prenatal vitamins iron supplements and natural menopause relief products under its vitamedmd brand name and authorized generic formulations of some of its prescription prenatal vitamin products under bocagreenmd prena name the company offers prescription prenatal vitamin product under its branded vitamedmd name as vitapearl and under its authorized generic prena name as prena pearl which features a combination of folmax feplus and purdha the companys product line includes vitatrue vitapearl vitamedmd plus vitamedmd one prenatal multivitamin vitamedmd plus rx prenatal multivitamin vitamedmd one rx prenatal multivitamin vitamedmd redichew rx prenatal multivitamin vitamedmd iron  itamedmd menopause relief with lifenol plus bone support vitamedmd vitamin d  iu bocagreenmd prena pearl and bocagreenmd prena chewthe companys vitatrue is a prenatal vitamin and is targeted at health conscious consumers vitatrue contains a complete multivitamin with  essential vitamins and minerals and  milligrams mg of plant based docosahexaenoic acid dha vitatrue is fish gluten lactose and sugar free vitapearl is a prenatal vitamin vitapearl delivers  vitamins and minerals plus  milligrams of dha as pardha providing support for pregnancy and nursing vitamedmd plus is a oncedaily two pill combo pack that contains a multivitamin with  essential vitamins and minerals and  milligrams of plantbased dha vitamedmd one is a singledose daily multivitamin that provides  vitamins and minerals and  milligrams of plantbased dha each softgel also features  micrograms of folic acid vitamedmd plus rx is a oncedaily two pill combo prescription product containing one prenatal vitamin tablet with quatrefolic and one plantbased dha  milligrams capsulevitamedmd one rx is a prescription product with a singledose daily multivitamin that provides  vitamins and minerals quatrefolic and  milligrams of plantbased dha vitamedmd redichew rx is a prescription vanillaflavored chewable tablet containing folmax vitamin d vitamin b vitamin b and vitamin b vitamedmd redichew rx is designed for women having difficulty in swallowing tablets or softgels or are experiencing nausea and morning sickness vitamedmd iron  is an iron replacement supplement with a three weeksonone weekoff dosing schedule intended to maximize absorption and enhance tolerability it is formulated with  milligrams of chelated iron to help improve tolerability and limit typical side effects associated with iron replacements each single tablet serving also includes  micrograms of folic acid plus vitamins c and b and succinic acid to aid in absorptionthe companys vitamedmd menopause relief with lifenol plus bone support offers a natural treatment for hot flashes night sweats and mood disturbances each single tablet dosage delivers  milligrams of lifenol a female hops extract recognized for its potency and support in alleviating hot flashes plus plant phytoestrogens it also includes calcium and vitamin d for added bone support vitamedmd vitamin d  iu is a dietary supplements provided in a gel capsule that helps to maintain beneficial levels of vitamin d in the body vitamedmd vitamin d  iu is ideal for pregnant breastfeeding and menopausal women to sustain adequate levels of vitamin d bocagreenmd prena pearl is an authorized generic of vitapearl a complete prenatal vitamin in one tiny pearl bocagreenmd prena chew is an authorized generic of vitamedmd redichew rx a prescription single daily vanillaflavored chewable tablet the companys hormone therapy drug candidates include txhr txhr txhr and txhr txhr is an oral combination of progesterone and estradiol txhr is a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil txhr is a natural estradiol formulation txhr is an applicatorfree vaginal estradiol softgel drug candidate for the treatment of vulvar and vaginal atrophy vva in postmenopausal women with vaginal linings that do not receive enough estrogenthe company competes with pfizer mylan barr and noven pharmaceuticals » full overview of txmdk company address therapeuticsmd inc  broken sound pkwy nwboca raton   fl    p  company web links home page officers  directors name compensation tommy thompson  john milligan  robert finizio  daniel cartwright  mitchell krassan  » more officers  directors therapeuticsmd inc news brieftherapeuticsmd provides txhr regulatory update jul   update fda rejects therapeuticsmds vaginal pain drug shares slump may   fda rejects therapeuticsmds vaginal pain drug may   brieftherapeuticsmd receives complete response letter from fda for txhr nda may   brieftherapeuticsmd announces q loss per share  may   » more txmdk news related topics stocksstock screenerhealthcarepharmaceuticals stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  txmd stock price  therapeuticsmd inc stock quote us nyse american  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated wall street isn’t ready for a point tumble in the dow industrials p barrons buzz robo  facebook and twitter trading on news p a wild week in washington p updated the dark side of cruises p trump to police dont be too nice p updated the highest paid athletes in the world in one chart p updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family p updated here are  coworkers you should avoid like the plague — especially in meetings p updated top  most annoying people you may want to unfriend on facebook p updated this is one person you should never unfriend on facebook to be replaced home investing quotes stocks united states txmd overview compare quotes stock screener earnings calendar sectors txmd us nyse american join td ameritrade find a broker therapeuticsmd inc watchlist createtxmdalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume m  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap b shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones dow closes at alltime high for second straight session dec   at  pm et by sue chang breaking therapeuticsmd shares jump  on menopause drug study results dec   at  pm et by wallace witkowski charting the bullbear debate ahead of the fed dec   at  am et by michael ashbaugh opinion  stocks to watch dec   at  pm et by harry boxer therapeuticsmd shares rally on menopause drug study data dec   at  pm et by wallace witkowski four biotech picks with  catalysts may   at  am et on barrons six biotechs to like right now jan   at  am et on barrons stocks to watch therapeuticsmd outerwall norfolk southern dec   at  am et on the wall street journal nyse halts trading in nine securities due to workstation issue nov   at  am et on the wall street journal recent news other news press releases carl domino inc buys vf corp twilio inc therapeuticsmd inc sells ei  carl domino inc buys vf corp twilio inc therapeuticsmd inc sells ei du pont de nemours nordic american tankers wynn resorts jul   at  pm et on gurufocuscom premarket analyst action  healthcare premarket analyst action  healthcare jul   at  am et on seeking alpha an irrational reaction to therapeuticsmds news release an irrational reaction to therapeuticsmds news release jul   at  pm et on seeking alpha cantor remains bullish on therapeuticsmd inc txmd as investors await clarity on tx cantor analyst william tanner is out with a research note on shares of therapeuticsmd inc nysemkttxmd after the  jul   at  pm et on smarteranalyst why therapeuticsmd inc is getting clobbered jul   at  am et on motley fool therapeuticsmd submits crlrelated data to fda review timeline undetermined shares down  premarket therapeuticsmd submits crlrelated data to fda review timeline undetermined shares down  premarket jul   at  am et on seeking alpha why therapeuticsmd inc is soaring today jul   at  am et on motley fool premarket gainers as of  am premarket gainers as of  am jul   at  am et on seeking alpha with an uncertain future therapeuticsmd looks to new prospects for survival with an uncertain future therapeuticsmd looks to new prospects for survival jul   at  am et on seeking alpha profit from therapeuticsmds upcoming fda catalyst profit from therapeuticsmds upcoming fda catalyst jul   at  am et on seeking alpha txmd option alert dec   calls at the ask    vs  oi ref txmd option alert dec   calls at the ask    vs  oi ref jun   at  pm et on benzingacom are options traders betting on a big move in therapeuticsmd txmd stock investors in therapeuticsmd txmd need to pay close attention to the stock based on moves in the options market lately jun   at  am et on zackscom are options traders betting on a big move in therapeuticsmd txmd stock therapeuticsmd txmd warrants investors attention based on moves in the options market lately may   at  am et on zackscom fda expresses concern on therapeuticsmd oppenheimer downgrades fda expresses concern on therapeuticsmd oppenheimer downgrades may   at  pm et on benzingacom analyst the nature of therapeuticsmd s crl from the fda is a bestcase scenario analyst the nature of therapeuticsmd s crl from the fda is a bestcase scenario may   at  am et on benzingacom premarket analyst action  healthcare premarket analyst action  healthcare may   at  am et on seeking alpha monday movers  breaking healthcare stories that will have longterm impacts monday movers  breaking healthcare stories that will have longterm impacts may   at  am et on seeking alpha  fda events to watch out for in may  here is a look at a few important regulatory events scheduled for the month of may including the fdas decision regarding the label expansion of mercks mrk keytruda may   at  am et on zackscom heres why therapeuticsmd inc stock is sinking today may   at  pm et on motley fool therapeuticsmd results worse than expected therapeuticsmd results worse than expected may   at  am et on benzingacom therapeuticsmd to host second quarter financial results conference call and webcast on august  therapeuticsmd to host second quarter financial results conference call and webcast on august  jul   at  pm et on businesswire  bzx technical reports on drug makers equities  therapeuticsmd glaxosmithkline novartis and impax labs technical reports on drug makers equities  therapeuticsmd glaxosmithkline novartis and impax labs jul   at  am et on pr newswire  prf therapeuticsmd provides txhr regulatory update therapeuticsmd provides txhr regulatory update jul   at  am et on businesswire  bzx todays research reports on stocks to watch therapeuticsmd inc and moleculin biotech inc todays research reports on stocks to watch therapeuticsmd inc and moleculin biotech inc jul   at  am et on accesswire deadline today lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm deadline today lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire deadline today txmd shareholder alert the law offices of vincent wong reminds investors of a class action involving therapeuticsmd inc and a lead plaintiff deadline of june   deadline today txmd shareholder alert the law offices of vincent wong reminds investors of a class action involving therapeuticsmd inc and a lead plaintiff deadline of june   jun   at  am et on globenewswire final deadline alert bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   final deadline alert bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   jun   at  am et on accesswire june  deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm june  deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire shareholder alert pomerantz law firm reminds shareholders with losses on their investment in therapeuticsmd inc of class action lawsuit and upcoming deadline  txmd shareholder alert pomerantz law firm reminds shareholders with losses on their investment in therapeuticsmd inc of class action lawsuit and upcoming deadline  txmd jun   at  pm et on pr newswire  prf deadline monday levi  korsinsky llp reminds shareholders of a class action to recover losses suffered by investors in therapeuticsmd inc and a lead plaintiff deadline of june    txmd deadline monday levi  korsinsky llp reminds shareholders of a class action to recover losses suffered by investors in therapeuticsmd inc and a lead plaintiff deadline of june    txmd jun   at  pm et on accesswire deadline alert  bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   deadline alert  bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   jun   at  am et on accesswire stocks under scanner in the drug makers space  therapeuticsmd glaxosmithkline novartis and tonix pharma stocks under scanner in the drug makers space  therapeuticsmd glaxosmithkline novartis and tonix pharma jun   at  am et on pr newswire  prf monday deadline lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm monday deadline lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire day deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm day deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire deadline alert bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   deadline alert bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   jun   at  am et on globenewswire upcoming deadline lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm upcoming deadline lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire day deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm day deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire txmd shareholder alert the law offices of vincent wong reminds investors of a class action involving therapeuticsmd inc and a lead plaintiff deadline of june   txmd shareholder alert the law offices of vincent wong reminds investors of a class action involving therapeuticsmd inc and a lead plaintiff deadline of june   jun   at  pm et on accesswire equity alert lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm equity alert lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire shareholder alert levi  korsinsky llp reminds shareholders of a class action to recover losses suffered by investors in therapeuticsmd inc and lead plaintiff deadline of june    txmd shareholder alert levi  korsinsky llp reminds shareholders of a class action to recover losses suffered by investors in therapeuticsmd inc and lead plaintiff deadline of june    txmd jun   at  am et on accesswire therapeuticsmd inc therapeuticsmd inc is a healthcare company which focuses on developing and commercializing products for women its technology symboda develops advanced hormone therapy pharmaceutical products to enable delivery of bioidentical hormones through a variety of dosage forms and administration routes the company also manufactures and distributes branded and generic prescription prenatal vitamins as well as overthecounter vitamins under the vitamedmd and bocagreenmd brands therapeuticsmd was founded by robert g finizio and brian a bernick in  and is headquartered in boca raton fl see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top upgrades downgrades for july   jul   at  am et on benzingacom fda expresses concern on therapeuticsmd oppenheimer downgrades may   at  pm et on benzingacom benzingas top upgrades downgrades for may   may   at  am et on benzingacom competitors name chg  market cap amag pharmaceuticals inc  m lannett co inc  m pfizer inc  b repros therapeutics inc  m abbvie inc  b competitor data provided by partner content trending tickers powered by dvax  mo  blcm  clmt  man  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience txmd contact us email alerts research symboda technology hormone therapy txhr txhr txhr transdermal programs clinical trial enrollment txhr oral progesterone therapeuticsmd temporarily stopped trial what it is txhr is an investigational progesterone product under consideration for the treatment of secondary amenorrhea this natural progesterone formulation does not contain the potentially allergenic component of peanut oil which is contained in currently available fdaapproved oral progesterone formulations the product is chemically identical to the hormone that naturally occurs in a woman’s body txhr has completed a pivotal pk study and we are reevaluating the phase  clinical development program development phase phase  under consideration in july  we temporarily suspended enrollment in the spry trial and in october  we temporarily stopped it in order to update the phase  protocol based on discussions with the fda we intend to update the phase  protocol to among other things target only those women with secondary amenorrhea due to polycystic ovarian syndrome and to amend the primary endpoint of the trial about amenorrhea amenorrhea is the absence of a menstrual period in a woman of reproductive age secondary amenorrhea menstruation cycles ceasing is often caused by hormonal disturbances from the hypothalamus and the pituitary gland from polycystic ovarian syndrome pcos or from premature menopause or intrauterine scar formation it is defined as the absence of menses for three months in a woman with previously normal menstruation   txmd contact us email alerts research symboda technology hormone therapy txhr txhr txhr transdermal programs clinical trial enrollment hormone therapy – medical overview menopause menopause is diagnosed after a woman has not had a menstrual period for twelve consecutive months at this time her ovaries have stopped releasing eggs and have largely stopped producing the hormones estrogen and progesterone according to the north american menopause society nams “most women experience menopause between ages  and  the average age is ” a woman may experience menopause as early as her thirties brought on by medical interventions such as having a hysterectomy or undergoing chemotherapy the american congress of obstetricians and gynecologists acog states that hot flashes and vaginal dryness are the most common menopause symptoms – with as many as  of menopausal women experiencing hot flashespostmenopausal women may experience vulvar and vaginal atrophy vva a component of genitourinary syndrome of menopause gsm vva is a medical condition caused by loss of estrogen after menopause one of the most bothersome symptoms of vva is dyspareunia vaginal pain from sexual activity additional symptoms may include vaginal dryness itching irritation and painful urination approximately  of menopausal women or  million women in the united states experience vva symptoms yet only about   million of these women use prescription treatment estrogen and estrogenprogestin therapy hormone therapy has been used for more than onehalf century for the management of menopausal symptoms such as vasomotor symptoms vms – hot flushes night sweats and postmenopausal symptoms associated with vulvar and vaginal atrophy vva vasomotor symptoms vms estrogen therapy the use of estrogen alone therapy is used in the treatment of moderate to severe vasomotor vms symptoms associated with menopause these symptoms appearing in postmenopausal women are called hot flashes or hot flushes the severity of vms symptoms may range from mild – the sensation of feeling hot without sweating moderate – the sensation of feeling hot accompanied by sweating and able to maintain activity severe – the sensation of feeling hot accompanied by sweating and needing to cease activity prescription estrogenalone therapy may be recommended for women who experience moderate to severe vasomotor symptoms and have had a hysterectomy estrogenprogestin therapy estrogenprogestin therapy may be recommended for women who experience vms symptoms particularly severe hot flashes and have not had a hysterectomy the addition of progestin is used to help counteract possible adverse effects of estrogen alone on the endometrium of women with their uterus intact vulvar and vaginal atrophy vva estrogen therapy estrogen therapy alone is also used locally in the treatment of moderate to severe vulvar and vaginal atrophy vva symptoms associated with menopause vva symptoms may include vaginal dryness dyspareunia vaginal pain associated with sexual intercourse dysuria painful urination vaginal itching or irritation bleeding after sexual intercourse references north american menopause society online menopause  a primer for the perimenopausal the basics httpwwwmenopauseorgforwomenmenopauseflashesmenopausesymptomsandtreatmentsmenopauseaprimerfortheperimenopausal menopause diseases and conditions the cleveland clinic online httpmyclevelandclinicorghealthdiseasesconditionshicwhatisperimenopausemenopausepostmenopause menopause resource overview the american congress of obstetricians and gynecologists httpwwwacogorgwomenshealthmenopause kingsberg s wysocki s magnus l krychman m vulvar and vaginal atrophy in postmenopausal women findings from the revive real women’s views of treatment options for menopausal vaginal changes survey j sex med –   txmd contact us email alerts research symboda technology hormone therapy txhr txhr txhr transdermal programs clinical trial enrollment txhr oral estradiol  progesterone what it is txhr is a novel combination of ßestradiol and progesterone using symboda technology under investigation for treating vasomotor symptoms vms related to menopause txhr is believed to be the first and only combination drug product candidate designed to replace the ßestradiol and progesterone hormones the ovary has nearly stopped producing about vms development phase phase  –the replenish trial the purpose of the replenish trial is to evaluate an investigational bioidentical medication that may help reduce the frequency and severity of vms symptoms particularly daily hot flashes and night sweats often experienced during menopause the phase  replenish trial was fully enrolled q  topline data anticipated q  – q  replenish trial study design summary  projected number of subjects    projected number of us sites    treatment arms narm estradiol  mgprogesterone  mg estradiol  mgprogesterone  mg estradiol  mgprogesterone  mg estradiol  mgprogesterone  mg placebo  length of study  month study for endometrial safety with week vasomotor substudy endpoints  endpoints vasomotor substudy number and severity of hot flashes weeks  and  endometrial safety incidence of endometrial hyperplasia  months about vasomotor symptoms vms it is estimated that more than  of women experience vms particularly frequent hot flashes and night sweats during menopause most rate the severity of their hot flashes as moderate to severe kingsberg s wysocki s magnus l and krychman m vulvar and vaginal atrophy in postmenopausal women findings from the revive real women’s views of treatment options for menopausal vaginal changes survey j sex med –   txmd contact us email alerts research symboda technology hormone therapy txhr txhr txhr transdermal programs clinical trial enrollment proprietary technologyresulting in novel drug candidates in key women’s healthcare categories symboda meaning “similar to the body” is a solubilized female hormone technology for formulation of estradiol and progesterone identical in chemical structure to the estradiol and progesterone that women naturally produceground breaking and uniquesymboda technology is unique because it enables partial or complete solubilization of progesterone or estradiol into mediumchain oils often derived from coconut oil this allows for the production of cohesive stable formulations and provides content uniformity and accuracy of dosingwell researched and complianttherapeuticsmd is leveraging this leadingedge technology to create new bioidentical drug forms and combinations that meet fda uniformity and stability requirementspractical applicationssymboda underlies two natural bioidentical hormone investigational products currently in latestage development at therapeuticsmd and several of its earlierstage investigational products visit the research section of our website to learn morepartner with usvisit our partnering page for details on how to leverage this technology by working with therapeuticsmd  to learn more about symboda technology in our research pipeline visit our research page txmd contact us email alerts products vitamedmd rx bocagreenmd products vitamedmd® is focused on providing quality prescription brand and generic dietary supplements that support women’s healthvitamedmd a therapeuticsmd® company has built lasting trusted relationships with our customers through these products and by providing knowledgeable caring customer service through vitacare™ prescription services    prescription prenatal vitamins vitamedmd rx delivers prescription prenatal vitamins to suit a woman’s needs whether she is planning a pregnancy pregnant or nursing – including vitapearl™ vitatrue™ vitamedmd redichew® rx and vitamedmd one rx learn more    generic prenatal vitamins bocagreenmd® offers quality generic prescription prenatal vitamins – prena pearl prena true and prena chew the only authorized generic prenatals for vitamedmd rx prenatal vitamins learn more flashratings  principles facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings principles  flashratings mission is to provide you  the investor  with as much honest and professional research on your investments as possible  we believe its much better to get a multitude of credible opinions on an investment than to arbitrarily follow any single advisor  be it your banker a friend or a tv pundit  flashratings does not provide advice our job is to accurately and objectively report on analysts credible research and opinions the only advice flashratings will ever give you is to absorb as much fundamental research and different opinions as possible and make your own decisions  flashratings favors covering analysts with proven track records but will cover all analysts as long as their research is honest and professional sign up » txmd key statistics  therapeuticsmd inc financial ratios  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close therapeuticsmd inc nyse american txmd go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus therapeuticsmd inc after hours  quotes are delayed by  min jul    pm txmd quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite todays close     change   day low day high    week low  week high   company description therapeuticsmd inc is a healthcare company which focuses on developing and commercializing products for women its technology symboda develops advanced hormone therapy pharmaceutical products to enable delivery of bioidentical hormones through a variety of dosage forms and administration route therapeuticsmd inc is a healthcare company which focuses on developing and commercializing products for women its technology symboda develops advanced hormone therapy pharmaceutical products to enable delivery of bioidentical hormones through a variety of dosage forms and administration routes the company also manufactures and distributes branded and generic prescription prenatal vitamins as well as overthecounter vitamins under the vitamedmd and bocagreenmd brands therapeuticsmd was founded by robert g finizio and brian a bernick in  and is headquartered in boca raton fl valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title mr john c k milligan   president  director mr robert g finizio   chief executive officer  director mr daniel alan cartwright   chief financial officer treasurer  vp dr brian a bernick   director  chief clinical officer dr c christine miller   chief compliance  regulatory officer insider actions – purchase – sale  – number of transactions  date name shares transaction value  robert g finizio ceo director    gift at  per share   robert g finizio ceo director    gift at  per share   brian a bernick director    gift at  per share   brian a bernick director      cooper c collins director    acquisition at  per share   robert g finizio ceo director    gift at  per share   john c k milligan presidentsecretary director    gift at  per share   angus c russell director    acquisition at  per share   tommy george thompson director    acquisition at  per share   tommy george thompson director    acquisition at  per share   tommy george thompson director    acquisition at  per share   mitchell l krassan evp chief strategy officer    disposition at  per share   mitchell l krassan evp chief strategy officer    derivativenonderivative trans at  per share   mitchell l krassan evp chief strategy officer    disposition at  per share   mitchell l krassan evp chief strategy officer    derivativenonderivative trans at  per share  newslatestcompanyustxmd marketwatch news on txmd dow closes at alltime high for second straight session  pm dec    sue chang therapeuticsmd shares jump  on menopause drug study results  pm dec    wallace witkowski charting the bullbear debate ahead of the fed  pm dec    michael ashbaugh  stocks to watch  pm dec    the trading deck therapeuticsmd shares rally on menopause drug study data  pm dec    wallace witkowski newsnonmarketwatchcompanyustxmd other news on txmd carl domino inc buys vf corp twilio inc therapeuticsmd inc sells ei   pm july    gurufocuscom premarket analyst action  healthcare  am july    seeking alpha an irrational reaction to therapeuticsmds news release  pm july    seeking alpha cantor remains bullish on therapeuticsmd inc txmd as investors await clarity on tx  pm july    smarteranalyst why therapeuticsmd inc is getting clobbered  am july    motley fool therapeuticsmd submits crlrelated data to fda review timeline undetermined shares down  premarket  am july    seeking alpha why therapeuticsmd inc is soaring today  am july    motley fool premarket gainers as of  am  am july    seeking alpha with an uncertain future therapeuticsmd looks to new prospects for survival  am july    seeking alpha profit from therapeuticsmds upcoming fda catalyst  am july    seeking alpha txmd option alert dec   calls at the ask    vs  oi ref  pm june    benzingacom are options traders betting on a big move in therapeuticsmd txmd stock  am june    zackscom are options traders betting on a big move in therapeuticsmd txmd stock  am may    zackscom fda expresses concern on therapeuticsmd oppenheimer downgrades  pm may    benzingacom premarket analyst action  healthcare  am may    seeking alpha analyst the nature of therapeuticsmd s crl from the fda is a bestcase scenario  am may    benzingacom monday movers  breaking healthcare stories that will have longterm impacts  am may    seeking alpha heres why therapeuticsmd inc stock is sinking today  pm may    motley fool therapeuticsmd results worse than expected  am may    benzingacom  fda events to watch out for in may   am may    zackscom loading more headlines at a glance therapeuticsmd inc  broken sound parkway nw rd floor boca raton florida  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue m net income m employees  annual report for txmd newspressreleasecompanyustxmd press releases on txmd therapeuticsmd to host second quarter financial results conference call and webcast on august   pm july    businesswire  bzx technical reports on drug makers equities  therapeuticsmd glaxosmithkline novartis and impax labs  am july    pr newswire  prf therapeuticsmd provides txhr regulatory update  am july    businesswire  bzx todays research reports on stocks to watch therapeuticsmd inc and moleculin biotech inc  am july    accesswire deadline today lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm  pm june    accesswire deadline today txmd shareholder alert the law offices of vincent wong reminds investors of a class action involving therapeuticsmd inc and a lead plaintiff deadline of june    am june    globenewswire final deadline alert bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june    am june    accesswire june  deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm  pm june    accesswire shareholder alert pomerantz law firm reminds shareholders with losses on their investment in therapeuticsmd inc of class action lawsuit and upcoming deadline  txmd  pm june    pr newswire  prf deadline monday levi  korsinsky llp reminds shareholders of a class action to recover losses suffered by investors in therapeuticsmd inc and a lead plaintiff deadline of june    txmd  pm june    accesswire deadline alert  bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june    am june    accesswire stocks under scanner in the drug makers space  therapeuticsmd glaxosmithkline novartis and tonix pharma  am june    pr newswire  prf monday deadline lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm  pm june    accesswire day deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm  pm june    accesswire deadline alert bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june    am june    globenewswire upcoming deadline lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm  pm june    accesswire day deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm  pm june    accesswire txmd shareholder alert the law offices of vincent wong reminds investors of a class action involving therapeuticsmd inc and a lead plaintiff deadline of june    pm june    accesswire equity alert lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm  pm june    accesswire shareholder alert levi  korsinsky llp reminds shareholders of a class action to recover losses suffered by investors in therapeuticsmd inc and lead plaintiff deadline of june    txmd  am june    accesswire loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  txmd contact us email alerts corporate highlights an innovative pharmaceutical company exclusively committed to advancing women’s health worldwide commercial rights for multiple hormone therapy products at various stages of clinical development products targeted to large underserved and growing markets experienced management team with proven development and commercial success in women’s health upcoming events flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry txmdnyse mkt llc stock quote  therapeuticsmd inc  bloomberg markets error could not add to watchlist x  watchlist therapeuticsmd inc txmdus nyse mkt llc usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap b usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases  analysts actions  costco jc penney cisco therapeuticsmd and more  the street there are currently no news stories for this ticker please check back later  therapeuticsmd to host second quarter financial results conference call and webcast on august   therapeuticsmd provides txhr regulatory update  deadline today txmd shareholder alert the law offices of vincent wong reminds investors of a class action involving therapeut  shareholder alert pomerantz law firm reminds shareholders with losses on their investment in therapeuticsmd inc of class ac  equity alert levi  korsinsky llp reminds shareholders of a class action to recover losses suffered by investors in therapeut  deadline alert bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead  june  deadline alert gpm reminds investors of looming deadline in the class action lawsuit against therapeuticsmd inc  shareholder alert pomerantz law firm announces the filing of a class action against therapeuticsmd inc and certain officers  the klein law firm reminds investors of a class action filed on behalf of therapeuticsmd inc shareholders and a lead plaintiff  the klein law firm announces a class action filed on behalf of therapeuticsmd inc shareholders and a lead plaintiff deadline there are currently no press releases for this ticker please check back later profile therapeuticsmd inc is a specialty pharmaceutical company focused on creating safe and effective branded and generic prescription and overthecounter products targeted exclusively for women the company is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopauserelated hormone deficiencies address  broken sound parkwaynorthwest rd floorboca raton fl united states phone  website wwwtherapeuticsmdcom executives board members robert g finizio ceocofounder john c k milligan presidentsecretary daniel a cartwright dan cfotreasurer sebastian mirkin chief medical officer julia amadio chief product officer show more flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising txmd contact us email alerts products vitamedmd rx bocagreenmd products vitamedmd® is focused on providing quality prescription brand and generic dietary supplements that support women’s healthvitamedmd a therapeuticsmd® company has built lasting trusted relationships with our customers through these products and by providing knowledgeable caring customer service through vitacare™ prescription services    prescription prenatal vitamins vitamedmd rx delivers prescription prenatal vitamins to suit a woman’s needs whether she is planning a pregnancy pregnant or nursing – including vitapearl™ vitatrue™ vitamedmd redichew® rx and vitamedmd one rx learn more    generic prenatal vitamins bocagreenmd® offers quality generic prescription prenatal vitamins – prena pearl prena true and prena chew the only authorized generic prenatals for vitamedmd rx prenatal vitamins learn more txmd stock price  therapeuticsmd inc stock quote us nyse american  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated wall street isn’t ready for a point tumble in the dow industrials p barrons buzz robo  facebook and twitter trading on news p a wild week in washington p updated the dark side of cruises p trump to police dont be too nice p updated the highest paid athletes in the world in one chart p updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family p updated here are  coworkers you should avoid like the plague — especially in meetings p updated top  most annoying people you may want to unfriend on facebook p updated this is one person you should never unfriend on facebook to be replaced home investing quotes stocks united states txmd overview compare quotes stock screener earnings calendar sectors txmd us nyse american join td ameritrade find a broker therapeuticsmd inc watchlist createtxmdalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume m  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap b shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones dow closes at alltime high for second straight session dec   at  pm et by sue chang breaking therapeuticsmd shares jump  on menopause drug study results dec   at  pm et by wallace witkowski charting the bullbear debate ahead of the fed dec   at  am et by michael ashbaugh opinion  stocks to watch dec   at  pm et by harry boxer therapeuticsmd shares rally on menopause drug study data dec   at  pm et by wallace witkowski four biotech picks with  catalysts may   at  am et on barrons six biotechs to like right now jan   at  am et on barrons stocks to watch therapeuticsmd outerwall norfolk southern dec   at  am et on the wall street journal nyse halts trading in nine securities due to workstation issue nov   at  am et on the wall street journal recent news other news press releases carl domino inc buys vf corp twilio inc therapeuticsmd inc sells ei  carl domino inc buys vf corp twilio inc therapeuticsmd inc sells ei du pont de nemours nordic american tankers wynn resorts jul   at  pm et on gurufocuscom premarket analyst action  healthcare premarket analyst action  healthcare jul   at  am et on seeking alpha an irrational reaction to therapeuticsmds news release an irrational reaction to therapeuticsmds news release jul   at  pm et on seeking alpha cantor remains bullish on therapeuticsmd inc txmd as investors await clarity on tx cantor analyst william tanner is out with a research note on shares of therapeuticsmd inc nysemkttxmd after the  jul   at  pm et on smarteranalyst why therapeuticsmd inc is getting clobbered jul   at  am et on motley fool therapeuticsmd submits crlrelated data to fda review timeline undetermined shares down  premarket therapeuticsmd submits crlrelated data to fda review timeline undetermined shares down  premarket jul   at  am et on seeking alpha why therapeuticsmd inc is soaring today jul   at  am et on motley fool premarket gainers as of  am premarket gainers as of  am jul   at  am et on seeking alpha with an uncertain future therapeuticsmd looks to new prospects for survival with an uncertain future therapeuticsmd looks to new prospects for survival jul   at  am et on seeking alpha profit from therapeuticsmds upcoming fda catalyst profit from therapeuticsmds upcoming fda catalyst jul   at  am et on seeking alpha txmd option alert dec   calls at the ask    vs  oi ref txmd option alert dec   calls at the ask    vs  oi ref jun   at  pm et on benzingacom are options traders betting on a big move in therapeuticsmd txmd stock investors in therapeuticsmd txmd need to pay close attention to the stock based on moves in the options market lately jun   at  am et on zackscom are options traders betting on a big move in therapeuticsmd txmd stock therapeuticsmd txmd warrants investors attention based on moves in the options market lately may   at  am et on zackscom fda expresses concern on therapeuticsmd oppenheimer downgrades fda expresses concern on therapeuticsmd oppenheimer downgrades may   at  pm et on benzingacom analyst the nature of therapeuticsmd s crl from the fda is a bestcase scenario analyst the nature of therapeuticsmd s crl from the fda is a bestcase scenario may   at  am et on benzingacom premarket analyst action  healthcare premarket analyst action  healthcare may   at  am et on seeking alpha monday movers  breaking healthcare stories that will have longterm impacts monday movers  breaking healthcare stories that will have longterm impacts may   at  am et on seeking alpha  fda events to watch out for in may  here is a look at a few important regulatory events scheduled for the month of may including the fdas decision regarding the label expansion of mercks mrk keytruda may   at  am et on zackscom heres why therapeuticsmd inc stock is sinking today may   at  pm et on motley fool therapeuticsmd results worse than expected therapeuticsmd results worse than expected may   at  am et on benzingacom therapeuticsmd to host second quarter financial results conference call and webcast on august  therapeuticsmd to host second quarter financial results conference call and webcast on august  jul   at  pm et on businesswire  bzx technical reports on drug makers equities  therapeuticsmd glaxosmithkline novartis and impax labs technical reports on drug makers equities  therapeuticsmd glaxosmithkline novartis and impax labs jul   at  am et on pr newswire  prf therapeuticsmd provides txhr regulatory update therapeuticsmd provides txhr regulatory update jul   at  am et on businesswire  bzx todays research reports on stocks to watch therapeuticsmd inc and moleculin biotech inc todays research reports on stocks to watch therapeuticsmd inc and moleculin biotech inc jul   at  am et on accesswire deadline today lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm deadline today lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire deadline today txmd shareholder alert the law offices of vincent wong reminds investors of a class action involving therapeuticsmd inc and a lead plaintiff deadline of june   deadline today txmd shareholder alert the law offices of vincent wong reminds investors of a class action involving therapeuticsmd inc and a lead plaintiff deadline of june   jun   at  am et on globenewswire final deadline alert bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   final deadline alert bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   jun   at  am et on accesswire june  deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm june  deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire shareholder alert pomerantz law firm reminds shareholders with losses on their investment in therapeuticsmd inc of class action lawsuit and upcoming deadline  txmd shareholder alert pomerantz law firm reminds shareholders with losses on their investment in therapeuticsmd inc of class action lawsuit and upcoming deadline  txmd jun   at  pm et on pr newswire  prf deadline monday levi  korsinsky llp reminds shareholders of a class action to recover losses suffered by investors in therapeuticsmd inc and a lead plaintiff deadline of june    txmd deadline monday levi  korsinsky llp reminds shareholders of a class action to recover losses suffered by investors in therapeuticsmd inc and a lead plaintiff deadline of june    txmd jun   at  pm et on accesswire deadline alert  bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   deadline alert  bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   jun   at  am et on accesswire stocks under scanner in the drug makers space  therapeuticsmd glaxosmithkline novartis and tonix pharma stocks under scanner in the drug makers space  therapeuticsmd glaxosmithkline novartis and tonix pharma jun   at  am et on pr newswire  prf monday deadline lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm monday deadline lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire day deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm day deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire deadline alert bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   deadline alert bronstein gewirtz  grossman llc reminds investors of class action against therapeuticsmd inc txmd  lead plaintiff deadline  june   jun   at  am et on globenewswire upcoming deadline lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm upcoming deadline lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire day deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm day deadline khang  khang llp announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire txmd shareholder alert the law offices of vincent wong reminds investors of a class action involving therapeuticsmd inc and a lead plaintiff deadline of june   txmd shareholder alert the law offices of vincent wong reminds investors of a class action involving therapeuticsmd inc and a lead plaintiff deadline of june   jun   at  pm et on accesswire equity alert lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm equity alert lundin law pc announces a securities class action lawsuit against therapeuticsmd inc and reminds investors with losses to contact the firm jun   at  pm et on accesswire shareholder alert levi  korsinsky llp reminds shareholders of a class action to recover losses suffered by investors in therapeuticsmd inc and lead plaintiff deadline of june    txmd shareholder alert levi  korsinsky llp reminds shareholders of a class action to recover losses suffered by investors in therapeuticsmd inc and lead plaintiff deadline of june    txmd jun   at  am et on accesswire therapeuticsmd inc therapeuticsmd inc is a healthcare company which focuses on developing and commercializing products for women its technology symboda develops advanced hormone therapy pharmaceutical products to enable delivery of bioidentical hormones through a variety of dosage forms and administration routes the company also manufactures and distributes branded and generic prescription prenatal vitamins as well as overthecounter vitamins under the vitamedmd and bocagreenmd brands therapeuticsmd was founded by robert g finizio and brian a bernick in  and is headquartered in boca raton fl see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top upgrades downgrades for july   jul   at  am et on benzingacom fda expresses concern on therapeuticsmd oppenheimer downgrades may   at  pm et on benzingacom benzingas top upgrades downgrades for may   may   at  am et on benzingacom competitors name chg  market cap amag pharmaceuticals inc  m lannett co inc  m pfizer inc  b repros therapeutics inc  m abbvie inc  b competitor data provided by partner content trending tickers powered by dvax  mo  blcm  clmt  man  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft therapeuticsmd inc txmd moves higher on volume spike for july   equitiescom breaking news previous next stocks end mixed as earnings continue in droves how to grow your new business ​mark dubowitz from the foundation for defense of democracies on us policy toward russia ​time for convertible securities ​working with  types of global influencers usglobal canada news log in login to your account log in remember me forgot your password forgot your username register news therapeuticsmd inc txmd moves higher on volume spike for july  equities staff follow  monday  july   est market summary  follow therapeuticsmd inc is a a womens health care product company last price   last trade jul   change   change percent   open   prev close   high   low    week high    week low   market cap  pe ratio  volume  exchange amx txmd  market data  news txmd  stock valuation report therapeuticsmd inc txmd traded on unusually high volume on jul  as the stock gained  to close at  on the day therapeuticsmd inc saw  million shares trade hands on  trades considering that the stock averages only a daily volume of  million shares a day over the last month this represents a pretty significant bump in volume over the norm generally speaking when a stock experiences a sudden spike in trading volume it may be seen as a bullish signal for investors an increase in volume means more market awareness for the company potentially setting up a more meaningful move in stock price the added volume also provides a level of support and stability for price advances the stock has traded between  and  over the last weeks its day sma is now  and its day sma  therapeuticsmd inc has a pb ratio of  therapeuticsmd inc is a womens health care company focused on creating and commercializing products targeted exclusively for women it is engaged in precommercialization activities for advanced hormone therapy pharmaceutical product headquartered in boca raton fl therapeuticsmd inc has  employees and is currently under the leadership of ceo robert g finizio for a complete fundamental analysis analysis of therapeuticsmd inc check out equitiescom’s stock valuation analysis report for txmd want to invest with the experts subscribe to equities premium newsletters today visit httpwwwequitiespremiumcom to learn more about guild investment’s market commentary and adam sarhan’s find leading stocks today to get more information on therapeuticsmd inc and to follow the company’s latest updates you can visit the company’s profile page here txmd’s profile for more news on the financial markets and emerging growth companies be sure to visit equitiescom’s newsdesk also don’t forget to signup for our daily email newsletter to ensure you don’t miss out on any of our best stories all data provided by quotemedia and was accurate as of pm et disclosure the views and opinions expressed in this article are those of the authors and do not represent the views of equitiescom readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions to read our full disclosure please go to httpwwwequitiescomdisclaimer comments you have to be logged in to leave a comment take me to log in dont have an account × you must log in first im sorry but in order to complete what youre trying to do you must be logged in take me to log in dont have an account im good for now more on equitiescom allpro aaron donald does not report to rams training camp boys  girls club youth receive  bicycle helmets safety and health tips from unitedhealthcare before the tour of utah tomra successful bid for network operator role in the new south wales container deposit scheme trending articles ​pro the new digital currency solves the biggest problem bitcoin can’t ​mgx minerals xmgcnx transforming oil wastewater to power the tech future ​liberty one’s pocitos west project positions it perfectly for the lithium supercycle ​nxtid’s fit pay adding secure shine to new token smart rings ​dynacert brings measurable efficiency to a global auto industry in need of reducing carbon emissions how millennials are changing the housing market emerging growth digital power corporation digital power corp is engaged in the design manufacture and sale of switching power supplies and converters the company has two reportable geographic segments  north america and europe private markets ipro network llc we provide the platform tools and resources to empower individuals and professionals to market desirable goods and services to the public taking the place of traditional methods of commerce mesamarshall  well project mesa resources mesa is sponsoring the development of the two well direct drilling project  mesamarshall  mesa founded in  is engaged in the acquisition exploration and development of… corporate sitepremium productsadvertisingrss feeds aboutcontactsite maptestimonials privacy policyterms and conditionsdisclaimerconference   equities  all dates and time are being displayed in eastern standard time est × follow companies mentioned in this article  follow therapeuticsmd inc therapeuticsmd inc txmd plunges  on july   equitiescom breaking news previous next stocks end mixed as earnings continue in droves how to grow your new business ​mark dubowitz from the foundation for defense of democracies on us policy toward russia ​time for convertible securities ​working with  types of global influencers usglobal canada news log in login to your account log in remember me forgot your password forgot your username register news therapeuticsmd inc txmd plunges  on july  equities staff follow  thursday  july   est market summary  follow therapeuticsmd inc is a a womens health care product company last price   last trade jul   change   change percent   open   prev close   high   low    week high    week low   market cap  pe ratio  volume  exchange amx txmd  market data  news txmd  stock valuation report therapeuticsmd inc txmd had a rough trading day for thursday july  as shares tumbled  or a loss of  per share to close at  after opening the day at  shares of therapeuticsmd inc traded as high as  and as low as  volume was  million shares over  trades against an average daily volume of  million shares and a total float of  million as a result of the decline therapeuticsmd inc now has a market cap of  billion in the last year shares of therapeuticsmd inc have traded between a range of  and  and its day sma is currently  and day sma is  for a complete fundamental analysis of therapeuticsmd inc check out equitiescom’s stock valuation analysis report for txmd want to invest with the experts subscribe to equities premium newsletters today visit httpwwwequitiespremiumcom to learn more about guild investment’s market commentary and adam sarhan’s find leading stocks today therapeuticsmd inc is a womens health care company focused on creating and commercializing products targeted exclusively for women it is engaged in precommercialization activities for advanced hormone therapy pharmaceutical product therapeuticsmd inc is based out of boca raton fl and has some  employees its ceo is robert g finizio therapeuticsmd inc is a component of the russell  the russell  is one of the leading indices tracking smallcap companies in the united states its maintained by russell investments an industry leader in creating and maintaining indices and consists of the smallest  stocks from the broader russell  index russells indices differ from traditional indices like the dow jones industrial average djia or sp  whose members are selected by committee because they base membership entirely on an objective rules based methodology the  largest companies by market cap make up the russell  with the  smaller companies making up the russell  its a simple approach that gives a broad unbiased look at the smallcap market as a whole to get more information on therapeuticsmd inc and to follow the company’s latest updates you can visit the company’s profile page here txmd’s profile for more news on the financial markets and emerging growth companies be sure to visit equitiescom’s newsdesk also don’t forget to signup for our daily email newsletter to ensure you don’t miss out on any of our best stories all data provided by quotemedia and was accurate as of pm et disclosure the views and opinions expressed in this article are those of the authors and do not represent the views of equitiescom readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions to read our full disclosure please go to httpwwwequitiescomdisclaimer comments you have to be logged in to leave a comment take me to log in dont have an account × you must log in first im sorry but in order to complete what youre trying to do you must be logged in take me to log in dont have an account im good for now more on equitiescom allpro aaron donald does not report to rams training camp boys  girls club youth receive  bicycle helmets safety and health tips from unitedhealthcare before the tour of utah tomra successful bid for network operator role in the new south wales container deposit scheme trending articles ​pro the new digital currency solves the biggest problem bitcoin can’t ​mgx minerals xmgcnx transforming oil wastewater to power the tech future ​liberty one’s pocitos west project positions it perfectly for the lithium supercycle ​nxtid’s fit pay adding secure shine to new token smart rings ​dynacert brings measurable efficiency to a global auto industry in need of reducing carbon emissions how millennials are changing the housing market emerging growth digital power corporation digital power corp is engaged in the design manufacture and sale of switching power supplies and converters the company has two reportable geographic segments  north america and europe private markets ipro network llc we provide the platform tools and resources to empower individuals and professionals to market desirable goods and services to the public taking the place of traditional methods of commerce mesamarshall  well project mesa resources mesa is sponsoring the development of the two well direct drilling project  mesamarshall  mesa founded in  is engaged in the acquisition exploration and development of… corporate sitepremium productsadvertisingrss feeds aboutcontactsite maptestimonials privacy policyterms and conditionsdisclaimerconference   equities  all dates and time are being displayed in eastern standard time est × follow companies mentioned in this article  follow therapeuticsmd inc txmd contact us email alerts about leadership board of directors partnering careers our mission  values medical affairs leadership teamexperienced resultsdriven leadership the therapeuticsmd management team has extensive experience and a proven track record of success in product innovation development and commercialization including within the women’s healthcare industry we believe that our leadership’s ability to leverage our robust intellectual property product pipeline and entrepreneurial spirit will continue to guide the company into a promising future executive team robert g finizio chief executive officer cofounder and director robert g finizio is the chief executive officer cofounder and director of therapeuticsmd mr finizio has  years of healthcare experience and cofounded therapeuticsmd in  leveraging his entrepreneurial and medication technology background into women’s health utilizing the company’s proprietary technologies mr finizio is leading therapeuticsmd through the clinical development and regulatory review for novel hormone therapy products targeting large unmet market needs related to menopause management globally in his current role mr finizio has raised more than  million in capital for the company mr finizio is a graduate of the university of miami and taught english in osaka japan before launching his healthcare career working in the operating room for endoscopy specialist incorporated esi in operational sales and regional management roles after esi mr finizio joined omnicell technologies a leader in medication management in  mr finizio cofounded medication and clinical technology vendor carefusion selling it to cardinal health in   previous profilenext profile  john milligan president john milligan is president of therapeuticsmd an experienced entrepreneurial healthcare executive mr milligan has more than  years of successful sales management business development and operations experience throughout his career he has leveraged his knowledge of the complex healthcare environment to create numerous successful companies he cofounded clinical technology vendor carefusion in  selling it to cardinal health in  mr milligan held executive sales and operation management positions with omnicell inc a provider of clinical workflow solutions serving software inc and hboc mckesson corporation eventually acquired the latter two companies mr milligan received his bachelor of science degree in management engineering from the united states naval academy  previous profilenext profile  dan cartwright chief financial officer dan cartwright is chief financial officer at therapeuticsmd his  years of financial management experience includes serving as chief financial officer in both the public and private sectors in addition to his experience in healthcare mr cartwright worked in the finance cable and telecommunications industries he has participated in several mergers and acquisitions including those involving american wireless systems telegeography and web corporation arush entertainment before holding his cfo positions mr cartwright worked for kpmg and pricewaterhousecoopers and was a certified public accountant in texas he earned his bachelor of science degree in accounting from arizona state university  previous profilenext profile  dawn halkuff chief commercial officer dawn halkuff has held numerous senior level commercial and marketing positions over  years most recently she was senior vice president of the pfizer consumer healthcare wellness organization and a member of the consumer global leadership team ms halkuff was also commercial lead for sales and marketing of the pfizer women’s health division focusing on the company’s reinvestment in hormone therapy treatment including premarin vaginal cream® and oral hot flash treatments from  to  ms halkuff was head of global innovation at weight watchers international where she created new weightloss products services and solutions for women worldwide she holds a ba in psychology from university of connecticut and an mba from pennsylvania state university  previous profilenext profile  development team brian bernick md facog cofounder and chief clinical officer dr brian bernick is cofounder and chief clinical officer at therapeuticsmd dr bernick is a practicing boardcertified obstetriciangynecologist with over  years of clinical medical experience dr bernick currently serves on the american college of obstetricians and gynecologists’ acog national committee on professional liability dr bernick was the department chair of obstetrics and gynecology at boca raton regional hospital and served on that hospital’s medical executive board as well as the board of directors of the palm beach medical society and vitalmd group holding llc the largest physicianowned and managed obstetriciansgynecologists group in florida dr bernick is the recipient of several national and regional awards including recognition by his peers as one of the top doctor’s in his specialty by castle connolly as well as the recipient of the american medical association foundation’s leadership award dr bernick has numerous publications in peerreviewed journals as well as having presented original research at numerous medical conferences dr bernick holds  patents focusing on drug therapies and analysis dr bernick is an associate professor of florida atlantic university college of medicine dr bernick holds a bachelor of arts degree in economics from northwestern university received his doctorate in medicine from the chicago medical school and completed his residency at the university of pennsylvania  previous profilenext profile  sebastian mirkin md chief medical officer dr sebastian mirkin is chief medical officer at therapeuticsmd dr mirkin has more than  years of clinical development and medical affairs experience in women’s health his experience includes global lead of women’s health clinical research at pfizer senior director clinical research women’s health at wyeth and global lead medical services at organon dr mirkin oversaw the development and successful marketing authorization of several novel medicines including duavee® conbriza® lybrel® and premarin® vaginal cream in the united states europe and japan dr mirkin holds a doctor of medicine degree from national university argentina trained in obstetricsgynecology dr mirkin completed his fellowship in reproductive medicine at the jones institute of reproductive medicine in norfolk virginia and was involved in several nih and pharmaceuticalsponsored clinical trials in reproduction contraception and menopausal health dr mirkin’s awards include the new young investigator award from the north american menopause society and the burroughs fellowship award from the society for gynecological investigation published extensively in the fields of menopause contraception and reproductive endocrinology dr mirkin is an ad hoc reviewer for multiple women’s healthrelated journals  previous profilenext profile  julia amadio chief product officer julia amadio is chief product officer at therapeuticsmd ms amadio has an extensive  year background in general management and in leading pharmaceutical marketing and product development organizations including johnson  johnson wyeth rhonepoulenc aventis and daiichi ms amadio earned her bachelor of science degree in accounting from st joseph’s university and a master of business administration degree from drexel university ms amadio is an active member and leader in the healthcare businesswomen’s association she was an adjunct lecturer in the pharmaceutical mba program at st joseph’s university and authored a chapter on marketing market research and insights in the book pharmaceutical development for women published by wiley  sons  previous profilenext profile  marlan walker jd general counsel marlan walker is general counsel at therapeuticsmd previously he was inhouse ip counsel for medicis pharmaceutical corporation which was acquired by valeant pharmaceutical international in december  in addition to his experience as an inhouse attorney mr walker has extensive experience in private practice at a number of nationally recognized law firms mr walker’s particular expertise is in the life science industries including longterm portfolio strategy and management patent preparation and prosecution contract negotiation and drafting lifecycle management and hatchwaxman he received his bachelor and master of science molecular biology degrees from brigham young university mr walker also received a juris doctor degree from the arizona state university sandra day o’connor college of law and master of laws degree in intellectual property law from george washington university law school  previous profilenext profile  christine miller pharmd chief regulatory and quality officer dr christine miller is chief regulatory and quality officer at therapeuticsmd dr miller has over thirty years of experience in pharmaceutical regulatory affairs quality assurance and drug development dr miller has submitted and obtained approval for many b and b new drug applications including applications for new chemical entities fast track and orphan designated products she also has experience with generic drugs otc drugs dietary supplements and international regulatory submissions from her tenure at bayer bausch  lomb mallinckrodt santarus sirion therapeutics and novartis consumer healthcare her most recent industry position was sr vice president drug development for sirion therapeutics dr miller was vice president of regulatory affairs and quality assurance for santarus and global vice president drug regulatory affairs for bausch  lomb prior to joining therapeuticsmd dr miller led the regulatory affairs nda practice for lachman consultants dr miller has a doctor of pharmacy degree from the university of nebraska  previous profilenext profile  operations team mitchell krassan chief strategy  performance officer mitchell krassan is chief strategy  performance officer at therapeuticsmd he has  years of operational and financial management experience prior to joining therapeuticsmd mr krassan was a principal in equimark limited a private investment company that provided its portfolio companies with resources in the form of executive management marketing and financial operations earlier on mr krassan was chief financial officer and chief operations officer of the reich group a fully integrated direct marketing company with a focus on strategic planning research and operations mr krassan started his career in the big six public accounting where he rose to the level of manager at arthur andersen focusing on operational consulting for closely held companies mr krassan received his bachelor of science degree in accounting from the university of maryland and his master of business administration in management from new york university  previous profilenext profile  jason spitz vice president of marketing jason spitz is vice president of marketing at therapeuticsmd mr spitz has over  years of marketing advertising and general management experience in the pharmaceutical and biopharmaceutical markets prior to therapeuticsmd mr spitz was managing director oncology  hematology at beacon healthcare communications mr spitz began his career at scheringplough pharmaceuticals as a sales representative rising within the organization over  years to lead a global pharmaceutical franchise he also held senior commercial leadership roles at aesgen inc and mgi pharma inc acquired by eisai inc mr spitz received his bachelor of business administration in marketing from the university of texas at austin and his master of business administration in pharmaceutical studies from fairleigh dickinson university  previous profilenext profile  christian bloomgren vice president of sales christian bloomgren is vice president of sales at therapeuticsmd mr bloomgren has  years of leadership experience in the pharmaceutical biotechnology and diagnostic industries prior to therapeuticsmd mr bloomgren was on the management team at viacell inc acquired by perkinelmer creating a successful national sales channel and later leading the specialty diagnostics business prior pharmaceutical experience includes women’s health product launch and sales management roles at eli lilly  company and kv pharmaceutical mr bloomgren served as an officer in the united states air force and earned a bachelor of science degree from california state university and a master of science degree from troy state university  previous profilenext profile  michael donegan vice president of finance michael donegan is vice president of finance at therapeuticsmd he has served in this role since april  mr donegan has a year background in accounting and finance he has spent a great portion of his career focused on accountingfinance infrastructure and compliance mr donegan has spent much of the last decade designing and implementing sarbanesoxley  compliance programs for companies of all sizes he has also had numerous responsibilities at large public companies in corporate financeaccounting roles that include finance systems global consolidations and sec reporting mr donegan began his career at ernst  young llp where he worked in both the audit and tax departments mr donegan has written and spoken on the topic of finance infrastructure and its impact on financial reporting having authored growth and profitability optimizing the finance function for small and emerging businesses copyright   by john wiley and sons inc all rights reserved mr donegan earned his bachelor of science in accounting and his master of accounting from the university of florida  previous profilenext profile  experienced resultdriven leadership the therapeuticsmd management team has extensive experience and a proven track record of success in product innovation development and commercialization  including within the womens healthcare industry we believe that our leaderships ability to leverage our robust intellectual property product pipeline and entrepeneurial spirit will continue to guide the company into a promising future executive team robert g finizio is the chief executive officer cofounder and director of therapeuticsmd mr finizio has  years of healthcare experience and cofounded therapeuticsmd in  leveraging his entrepreneurial and medication technology background into women’s health utilizing the company’s proprietary technologies mr finizio is leading therapeuticsmd through the clinical development and regulatory review for novel hormone therapy products targeting large unmet market needs related to menopause management globally in his current role mr finizio has raised more than  million in capital for the company mr finizio is a graduate of the university of miami and taught english in osaka japan before launching his healthcare career working in the operating room for endoscopy specialist incorporated esi in operational sales and regional management roles after esi mr finizio joined omnicell technologies a leader in medication management in  mr finizio cofounded medication and clinical technology vendor carefusion selling it to cardinal health in  john milligan is president of therapeuticsmd an experienced entrepreneurial healthcare executive mr milligan has more than  years of successful sales management business development and operations experience throughout his career he has leveraged his knowledge of the complex healthcare environment to create numerous successful companies he cofounded clinical technology vendor carefusion in  selling it to cardinal health in  mr milligan held executive sales and operation management positions with omnicell inc a provider of clinical workflow solutions serving software inc and hboc mckesson corporation eventually acquired the latter two companies mr milligan received his bachelor of science degree in management engineering from the united states naval academy dan cartwright is chief financial officer at therapeuticsmd his  years of financial management experience includes serving as chief financial officer in both the public and private sectors in addition to his experience in healthcare mr cartwright worked in the finance cable and telecommunications industries he has participated in several mergers and acquisitions including those involving american wireless systems telegeography and web corporation arush entertainment before holding his cfo positions mr cartwright worked for kpmg and pricewaterhousecoopers and was a certified public accountant in texas he earned his bachelor of science degree in accounting from arizona state university dawn halkuff has held numerous senior level commercial and marketing positions over  years most recently she was senior vice president of the pfizer consumer healthcare wellness organization and a member of the consumer global leadership team ms halkuff was also commercial lead for sales and marketing of the pfizer women’s health division focusing on the company’s reinvestment in hormone therapy treatment including premarin vaginal cream® and oral hot flash treatments from  to  ms halkuff was head of global innovation at weight watchers international where she created new weightloss products services and solutions for women worldwide she holds a ba in psychology from university of connecticut and an mba from pennsylvania state university development team dr brian bernick is cofounder and chief clinical officer at therapeuticsmd dr bernick is a practicing boardcertified obstetriciangynecologist with over  years of clinical medical experience dr bernick currently serves on the american college of obstetricians and gynecologists’ acog national committee on professional liability dr bernick was the department chair of obstetrics and gynecology at boca raton regional hospital and served on that hospital’s medical executive board as well as the board of directors of the palm beach medical society and vitalmd group holding llc the largest physicianowned and managed obstetriciansgynecologists group in florida dr bernick is the recipient of several national and regional awards including recognition by his peers as one of the top doctor’s in his specialty by castle connolly as well as the recipient of the american medical association foundation’s leadership award dr bernick has numerous publications in peerreviewed journals as well as having presented original research at numerous medical conferences dr bernick holds  patents focusing on drug therapies and analysis dr bernick is an associate professor of florida atlantic university college of medicine dr bernick holds a bachelor of arts degree in economics from northwestern university received his doctorate in medicine from the chicago medical school and completed his residency at the university of pennsylvania dr sebastian mirkin is chief medical officer at therapeuticsmd dr mirkin has more than  years of clinical development and medical affairs experience in women’s health his experience includes global lead of women’s health clinical research at pfizer senior director clinical research women’s health at wyeth and global lead medical services at organon dr mirkin oversaw the development and successful marketing authorization of several novel medicines including duavee® conbriza® lybrel® and premarin® vaginal cream in the united states europe and japan dr mirkin holds a doctor of medicine degree from national university argentina trained in obstetricsgynecology dr mirkin completed his fellowship in reproductive medicine at the jones institute of reproductive medicine in norfolk virginia and was involved in several nih and pharmaceuticalsponsored clinical trials in reproduction contraception and menopausal health dr mirkin’s awards include the new young investigator award from the north american menopause society and the burroughs fellowship award from the society for gynecological investigation published extensively in the fields of menopause contraception and reproductive endocrinology dr mirkin is an ad hoc reviewer for multiple women’s healthrelated journals julia amadio is chief product officer at therapeuticsmd ms amadio has an extensive  year background in general management and in leading pharmaceutical marketing and product development organizations including johnson  johnson wyeth rhonepoulenc aventis and daiichi ms amadio earned her bachelor of science degree in accounting from st joseph’s university and a master of business administration degree from drexel university ms amadio is an active member and leader in the healthcare businesswomen’s association she was an adjunct lecturer in the pharmaceutical mba program at st joseph’s university and authored a chapter on marketing market research and insights in the book pharmaceutical development for women published by wiley  sons marlan walker is general counsel at therapeuticsmd previously he was inhouse ip counsel for medicis pharmaceutical corporation which was acquired by valeant pharmaceutical international in december  in addition to his experience as an inhouse attorney mr walker has extensive experience in private practice at a number of nationally recognized law firms mr walker’s particular expertise is in the life science industries including longterm portfolio strategy and management patent preparation and prosecution contract negotiation and drafting lifecycle management and hatchwaxman he received his bachelor and master of science molecular biology degrees from brigham young university mr walker also received a juris doctor degree from the arizona state university sandra day o’connor college of law and master of laws degree in intellectual property law from george washington university law school dr christine miller is chief regulatory and quality officer at therapeuticsmd dr miller has over thirty years of experience in pharmaceutical regulatory affairs quality assurance and drug development dr miller has submitted and obtained approval for many b and b new drug applications including applications for new chemical entities fast track and orphan designated products she also has experience with generic drugs otc drugs dietary supplements and international regulatory submissions from her tenure at bayer bausch  lomb mallinckrodt santarus sirion therapeutics and novartis consumer healthcare her most recent industry position was sr vice president drug development for sirion therapeutics dr miller was vice president of regulatory affairs and quality assurance for santarus and global vice president drug regulatory affairs for bausch  lomb prior to joining therapeuticsmd dr miller led the regulatory affairs nda practice for lachman consultants dr miller has a doctor of pharmacy degree from the university of nebraska operations team mitchell krassan is chief strategy  performance officer at therapeuticsmd he has  years of operational and financial management experience prior to joining therapeuticsmd mr krassan was a principal in equimark limited a private investment company that provided its portfolio companies with resources in the form of executive management marketing and financial operations earlier on mr krassan was chief financial officer and chief operations officer of the reich group a fully integrated direct marketing company with a focus on strategic planning research and operations mr krassan started his career in the big six public accounting where he rose to the level of manager at arthur andersen focusing on operational consulting for closely held companies mr krassan received his bachelor of science degree in accounting from the university of maryland and his master of business administration in management from new york university jason spitz is vice president of marketing at therapeuticsmd mr spitz has over  years of marketing advertising and general management experience in the pharmaceutical and biopharmaceutical markets prior to therapeuticsmd mr spitz was managing director oncology  hematology at beacon healthcare communications mr spitz began his career at scheringplough pharmaceuticals as a sales representative rising within the organization over  years to lead a global pharmaceutical franchise he also held senior commercial leadership roles at aesgen inc and mgi pharma inc acquired by eisai inc mr spitz received his bachelor of business administration in marketing from the university of texas at austin and his master of business administration in pharmaceutical studies from fairleigh dickinson university christian bloomgren is vice president of sales at therapeuticsmd mr bloomgren has  years of leadership experience in the pharmaceutical biotechnology and diagnostic industries prior to therapeuticsmd mr bloomgren was on the management team at viacell inc acquired by perkinelmer creating a successful national sales channel and later leading the specialty diagnostics business prior pharmaceutical experience includes women’s health product launch and sales management roles at eli lilly  company and kv pharmaceutical mr bloomgren served as an officer in the united states air force and earned a bachelor of science degree from california state university and a master of science degree from troy state university michael donegan is vice president of finance at therapeuticsmd he has served in this role since april  mr donegan has a year background in accounting and finance he has spent a great portion of his career focused on accountingfinance infrastructure and compliance mr donegan has spent much of the last decade designing and implementing sarbanesoxley  compliance programs for companies of all sizes he has also had numerous responsibilities at large public companies in corporate financeaccounting roles that include finance systems global consolidations and sec reporting mr donegan began his career at ernst  young llp where he worked in both the audit and tax departments mr donegan has written and spoken on the topic of finance infrastructure and its impact on financial reporting having authored growth and profitability optimizing the finance function for small and emerging businesses copyright   by john wiley and sons inc all rights reserved mr donegan earned his bachelor of science in accounting and his master of accounting from the university of florida